Literature DB >> 17052686

Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy.

Wenjing Zheng1, Jessica Kollmeyer, Holly Symolon, Amin Momin, Elizabeth Munter, Elaine Wang, Samuel Kelly, Jeremy C Allegood, Ying Liu, Qiong Peng, Harsha Ramaraju, M Cameron Sullards, Myles Cabot, Alfred H Merrill.   

Abstract

Sphingolipids are comprised of a backbone sphingoid base that may be phosphorylated, acylated, glycosylated, bridged to various headgroups through phosphodiester linkages, or otherwise modified. Organisms usually contain large numbers of sphingolipid subspecies and knowledge about the types and amounts is imperative because they influence membrane structure, interactions with the extracellular matrix and neighboring cells, vesicular traffic and the formation of specialized structures such as phagosomes and autophagosomes, as well as participate in intracellular and extracellular signaling. Fortunately, "sphingolipidomic" analysis is becoming feasible (at least for important subsets such as all of the backbone "signaling" subspecies: ceramides, ceramide 1-phosphates, sphingoid bases, sphingoid base 1-phosphates, inter alia) using mass spectrometry, and these profiles are revealing many surprises, such as that under certain conditions cells contain significant amounts of "unusual" species: N-mono-, di-, and tri-methyl-sphingoid bases (including N,N-dimethylsphingosine); 3-ketodihydroceramides; N-acetyl-sphingoid bases (C2-ceramides); and dihydroceramides, in the latter case, in very high proportions when cells are treated with the anticancer drug fenretinide (4-hydroxyphenylretinamide). The elevation of DHceramides by fenretinide is befuddling because the 4,5-trans-double bond of ceramide has been thought to be required for biological activity; however, DHceramides induce autophagy and may be important in the regulation of this important cellular process. The complexity of the sphingolipidome is hard to imagine, but one hopes that, when partnered with other systems biology approaches, the causes and consequences of the complexity will explain how these intriguing compounds are involved in almost every aspect of cell behavior and the malfunctions of many diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052686     DOI: 10.1016/j.bbamem.2006.08.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  207 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Shaping the landscape: metabolic regulation of S1P gradients.

Authors:  Ana Olivera; Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2012-06-23

3.  Regulation of autophagic activity by 14-3-3ζ proteins associated with class III phosphatidylinositol-3-kinase.

Authors:  M Pozuelo-Rubio
Journal:  Cell Death Differ       Date:  2010-10-01       Impact factor: 15.828

Review 4.  Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.

Authors:  Fei Yin; Harsh Sancheti; Zhigang Liu; Enrique Cadenas
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

5.  Inhibitors of ceramide de novo biosynthesis rescue damages induced by cigarette smoke in airways epithelia.

Authors:  Aida Zulueta; Anna Caretti; Giuseppe Matteo Campisi; Andrea Brizzolari; Jose Luis Abad; Rita Paroni; Paola Signorelli; Riccardo Ghidoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-13       Impact factor: 3.000

6.  Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.

Authors:  Makoto Taniguchi; Kazuyuki Kitatani; Tadakazu Kondo; Mayumi Hashimoto-Nishimura; Satoshi Asano; Akira Hayashi; Susumu Mitsutake; Yasuyuki Igarashi; Hisanori Umehara; Hiroyuki Takeya; Junzo Kigawa; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

7.  Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency.

Authors:  Ji-Hye Kang; Himanshu Garg; Dina M Sigano; Nicholas Francella; Robert Blumenthal; Victor E Marquez
Journal:  Bioorg Med Chem       Date:  2009-01-11       Impact factor: 3.641

8.  Evidence for the involvement of GD3 ganglioside in autophagosome formation and maturation.

Authors:  Paola Matarrese; Tina Garofalo; Valeria Manganelli; Lucrezia Gambardella; Matteo Marconi; Maria Grasso; Antonella Tinari; Roberta Misasi; Walter Malorni; Maurizio Sorice
Journal:  Autophagy       Date:  2014-02-10       Impact factor: 16.016

Review 9.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

10.  Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling.

Authors:  Hiroko Hamai; Fannie Keyserman; Lynne M Quittell; Tilla S Worgall
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.